Alexion Pharmaceuticals Inc. (ALXN) Provides Update On Previously Communicated November 2013 Voluntary Nationwide Recall Of Two Lots Of Soliris® (eculizumab) Concentrated Solution For Intravenous Infusion
12/16/2013 8:51:58 AM
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today is providing further information regarding a previously communicated voluntary recall of two lots of Soliris® (eculizumab) Concentrated Solution for Intravenous Infusion. As stated on Nov. 12, 2013, the two lots were found to contain visible particles. At that time, Alexion provided instructions to return any unused vials of Soliris from these two lots at the distributor level. Alexion is now providing the same instructions at the hospital/user level.
Help employers find you! Check out all the jobs and post your resume.
comments powered by